Metabasis Therapeutics News - MBRX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
LEVEL 1 STARTER
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Metabasis Therapeutics MBRX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.137 +14.08% 1.11 1.19 1.01 1.08 0.973 19:59:50
more quote information »

Recent News

Date Time Source Heading
4/18/201907:30PRNUSMoleculin Receives FDA Approval of Fast Track Designation..
4/17/201907:30PRNUSMoleculin Announces Significant Discovery in Lung Cancer..
4/16/201916:13EDGARProxy Statement (definitive) (def 14a)
4/12/201916:06EDGARProxy Soliciting Materials (revised) (prer14a)
4/11/201916:12EDGARCurrent Report Filing (8-k)
4/11/201907:30PRNUSMoleculin Announces Agreement with Emory University to..
4/09/201907:30PRNUSMoleculin Announces Successful Expansion of its Leukemia..
4/08/201917:25EDGARStatement of Ownership (sc 13g)
4/05/201917:29EDGARProxy Statement - Notice of Shareholders Meeting..
4/03/201907:30PRNUSMoleculin Announces Preclinical Pancreatic Cancer Data..
4/01/201903:10PRNCAEnerCube Completes Complex Design Project With Altasteel
4/01/201903:10PRNUSEnerCube Completes Complex Design Project With Altasteel
4/01/201903:10PRNUSEnerCube Completes Complex Design Project With Altasteel
3/29/201906:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/28/201906:19EDGARCurrent Report Filing (8-k)
3/27/201909:05PRNUSMoleculin Announces Pricing Of Underwritten Public Offering
3/26/201917:37PRNUSMoleculin Announces Proposed Underwritten Public Offering
3/26/201917:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/26/201907:33EDGARCurrent Report Filing (8-k)
3/26/201907:30PRNUSMoleculin Announces Positive Interim Results in First Cohort..
3/19/201907:30PRNUSMoleculin Announces First Patients Enrolled in Lymphoma..
3/18/201916:05PRNUSMoleculin Announces Memorial Sloan Kettering Chief of..
3/18/201916:02EDGARCurrent Report Filing (8-k)
3/18/201907:30PRNUSMoleculin Biotech, Inc. to Present at the Oppenheimer 29th..
3/14/201916:23EDGARCurrent Report Filing (8-k)
2/21/201916:59GLOBEMoleculin Biotech, Inc. Reports Financial Results for the..
2/21/201916:35EDGARCurrent Report Filing (8-k)
2/21/201916:34EDGARAnnual Report (10-k)
2/20/201907:30GLOBEMoleculin Announces Outlicensing Deal To Accelerate..
2/19/201903:05PRNCANorthern Lights Supply Store in Alberta Receives First..
2/19/201903:05PRNUSNorthern Lights Supply Store in Alberta Receives First..
2/19/201903:05PRNUSNorthern Lights Supply Store in Alberta Receives First..
2/14/201907:30PRNCAPremier Health Provides Corporate Update
2/14/201907:30PRNUSPremier Health Provides Corporate Update
2/14/201907:30PRNUSPremier Health Provides Corporate Update
2/07/201916:03EDGARCurrent Report Filing (8-k)
2/07/201907:30GLOBEMoleculin Announces Approval for Third Drug to Commence..
2/05/201916:28EDGARCurrent Report Filing (8-k)
2/05/201907:30GLOBEMoleculin Announces the FDA has Granted Orphan Drug..
1/17/201907:30GLOBEMoleculin Announces Dr. James L. Abbruzzese, Chief of..
1/15/201917:02EDGARCurrent Report Filing (8-k)
1/09/201907:30GLOBEMoleculin Announces Patient Recruitment Begins in Annamycin..
1/07/201917:02EDGARCurrent Report Filing (8-k)
1/03/201916:51EDGARAmended Statement of Ownership (sc 13g/a)
1/03/201907:30GLOBEMoleculin Announces Positive Data for its Pancreatic Cancer..
12/12/201817:30EDGARCurrent Report Filing (8-k)
12/11/201807:30GLOBEREMINDER: Moleculin Announces Conference Call to Discuss..
12/06/201816:05GLOBEMoleculin Announces Conference Call to Discuss FDA Filing..
12/06/201807:30GLOBEMoleculin Announces FDA Filing for Orphan Drug Designation..
12/04/201807:30GLOBEMoleculin Announces Breakthrough Discovery for its WP1066
See more news about this stock »


Your Recent History
NASDAQ
MBRX
Metabasis ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.